Boxer Capital, LLC’s Xenon Pharmaceuticals Inc Position
Does Boxer Capital, LLC own Xenon Pharmaceuticals Inc (XENE)? Not currently — the last reported position was 600.0K shares worth $24M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.
Position Value
$24M
Q3 2024
Shares
600.0K
% of Portfolio
+1.16%
Quarters Held
17
position exited
Position History XENE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 600.0K | $24M | +1.16% |
| Q2 2024 | 600.0K | $23M | +1.23% |
| Q1 2024 | 600.0K | $26M | +1.28% |
| Q4 2023 | 600.0K | $28M | +1.38% |
| Q3 2023 | 600.0K | $20M | +1.09% |
| Q2 2023 | 600.0K | $23,100 | +1.07% |
| Q1 2023 | 600.0K | $21,474 | +1.05% |
| Q4 2022 | 600.0K | $24M | +1.25% |
| Q3 2022 | 600.0K | $22M | +1.22% |
| Q2 2022 | 600.0K | $18M | +1.16% |
| Q1 2022 | 600.0K | $18M | +0.94% |
| Q4 2021 | 600.0K | $19M | +0.73% |
| Q3 2021 | 857.0K | $13M | +0.46% |
| Q2 2021 | 857.0K | $16M | +0.56% |
| Q3 2020 | 600.0K | $7M | +0.23% |
| Q2 2020 | 600.0K | $8M | +0.33% |
| Q1 2020 | 600.0K | $7M | +0.46% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of XENE.